These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 15381368)
1. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin. Bendig I; Mohr N; Kramer F; Weber BH Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368 [TBL] [Abstract][Full Text] [Related]
2. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456 [TBL] [Abstract][Full Text] [Related]
3. High frequency of de novo mutations in Li-Fraumeni syndrome. Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618 [TBL] [Abstract][Full Text] [Related]
4. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
5. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432 [TBL] [Abstract][Full Text] [Related]
6. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations. Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465 [TBL] [Abstract][Full Text] [Related]
8. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819 [TBL] [Abstract][Full Text] [Related]
10. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208 [TBL] [Abstract][Full Text] [Related]
11. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?]. Trková M; Sedlácek Z Cas Lek Cesk; 2003; 142(4):220-5. PubMed ID: 12841124 [TBL] [Abstract][Full Text] [Related]
12. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation]. Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T; J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570 [TBL] [Abstract][Full Text] [Related]
14. Three germline mutations in the TP53 gene. Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756 [TBL] [Abstract][Full Text] [Related]
15. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies. Pötzsch C; Voigtländer T; Lübbert M J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603 [TBL] [Abstract][Full Text] [Related]
16. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995 [TBL] [Abstract][Full Text] [Related]
17. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Tabori U; Nanda S; Druker H; Lees J; Malkin D Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077 [TBL] [Abstract][Full Text] [Related]
19. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation. Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079 [TBL] [Abstract][Full Text] [Related]
20. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families. Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]